Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Pettipher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skinV C Ridger, E R Pettipher, C E Bryant, et al.
British Journal of Pharmacology|September 1, 1993
Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responsesE R Pettipher, E D Salter, R Breslow, et al.
British Journal of Pharmacology|April 1, 1996
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipramE R Pettipher, J M Labasi, E D Salter, et al.
The Journal of Experimental Medicine|April 1, 1996
Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitisR P Gladue, L A Carroll, A J Milici, et al.
British Journal of Pharmacology|November 1, 1996
2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivoW S Faraci, A A Nagel, K A Verdries, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritisR J Griffiths, E R Pettipher, K Koch, et al.
Journal of Medicinal Chemistry|September 30, 1994
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis modelK Koch, L S Melvin, L A Reiter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696H J Showell, E R Pettipher, J B Cheng, et al.
Journal of Medicinal Chemistry|February 17, 1998
Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4E F Kleinman, E Campbell, L A Giordano, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skinV C Ridger, E R Pettipher, C E Bryant, et al.
British Journal of Pharmacology|September 1, 1993
Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responsesE R Pettipher, E D Salter, R Breslow, et al.
British Journal of Pharmacology|April 1, 1996
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipramE R Pettipher, J M Labasi, E D Salter, et al.
The Journal of Experimental Medicine|April 1, 1996
Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitisR P Gladue, L A Carroll, A J Milici, et al.
British Journal of Pharmacology|November 1, 1996
2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivoW S Faraci, A A Nagel, K A Verdries, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritisR J Griffiths, E R Pettipher, K Koch, et al.
Journal of Medicinal Chemistry|September 30, 1994
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis modelK Koch, L S Melvin, L A Reiter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696H J Showell, E R Pettipher, J B Cheng, et al.
Journal of Medicinal Chemistry|February 17, 1998
Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4E F Kleinman, E Campbell, L A Giordano, et al.
Pageof 4